New horizons for zoledronic acid: results of the HORIZON trials in postmenopausal women with osteoporosis and after hip fracture.
Doggrell
Sheila A
SA
RMIT University, Discipline of Pharmaceutical Sciences, School of Medicinal Sciences, Bundoora, VIC3083, Australia. sheila.doggrell@bigpond.com